Marex Group’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Marex Group’s Portfolio YCBD.PRA Stock Details YCBD.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-164,677	Closed	-$222K	–	978
2025 Q1	$222K	Buy	164,677 +77,344	+89%	+$92.5K	﹤0.01%	557
2024 Q4	$64.6K	Buy	87,333 +32,732	+60%	+$23.1K	﹤0.01%	633
2024 Q3	$37.6K	Buy	54,601 +15,337	+39%	+$8.13K	﹤0.01%	571
2024 Q2	$24.3K	Sell	39,264 -1,446	-4%	-$985	﹤0.01%	609
2024 Q1	$33.7K	Buy	40,710 +29,485	+263%	+$19.7K	﹤0.01%	452
2023 Q4	$7.86K	Buy	+11,225	New	+$10.6K	﹤0.01%	549

Marex Group's YCBD.PRA Position: Q2 2025 in Review

Marex Group sold out of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) in Q2 2025, closing a stake of 164,677 shares — an estimated $222K sold.

Marex Group first reported a position in YCBD.PRA in Q4 2023 and held it in 6 quarters. The position peaked at $222K in Q1 2025. 0 funds tracked by Wall St. Rank hold YCBD.PRA as of Q2 2025.

Marex Group reported no remaining cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position as of Q2 2025 after selling out during the quarter.
Marex Group sold 164,677 cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock shares in Q2 2025, an estimated $222K.
Marex Group first reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in Q4 2023 and held it in 6 quarters.
Marex Group's cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position peaked at $222K in Q1 2025.
0 funds tracked by Wall St. Rank held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock as of Q2 2025.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.